SUMMIT INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Summit Therapeutics Inc. (SMMT) and Encourages SMMT Investors to Contact the Firm

PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit”) on behalf of the Company’s investors.

The investigation seeks to determine whether Summit issued false and misleading statements and/or failed to disclose material facts to its investors, thereby violating the securities laws and causing harm to the company’s shareholders.

Summit shareholders

are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (

[email protected]

) or online at

, for additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit This notice may constitute attorney advertising in certain jurisdictions.


D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 – 0750